Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
NCT07097012Phase 4Recruiting
- Sponsor
- Canadian Immunization Research Network
- Start
- Oct 2025
- Primary completion
- Jan 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of tdap vaccine, RSV vaccine in pertussis, respiratory syncytial virus infection (RSV), sponsored by Canadian Immunization Research Network. Started Oct 2025; status: recruiting.
02
Drugs
tdap vaccineRSV vaccine
03
Conditions
pertussisrespiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT07097012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07097012.